Pink cocaine: the party drug cocktail putting a growing number of lives at risk

Despite its name, pink cocaine doesn’t necessarily contain any cocaine. Instead, it’s often a mixture of various other substances, including MDMA, ketamine and 2C-B. MDMA, commonly known as ecstasy, is a stimulant with psychedelic properties while ketamine is a powerful anaesthetic which has sedative and hallucinogenic effects. 2C drugs are classed as psychedelics but they can also produce stimulant effects.

The original psychedelic form of the drug dates to 1974 and was first synthesised by American biochemist, Alexander Shulgin. But the modern variant emerged around 2010 in Colombia and is a knock-off version.

The drug gained popularity on the party scene in Latin America and has now spread to Europe. Common names for pink cocaine vary widely, from “cocaina rosada” and “tuci” to “Venus” and “Eros”.

Russian roulette

Today’s pink cocaine is an unpredictable mix of substances and that is where much of its danger lies. Users often expect a stimulant similar to cocaine, but the inclusion of ketamine can lead to serious health risks. Abuse of ketamine, which is widely available as a club drug, can lead to unconsciousness or dangerously laboured breathing. This in turn increases the potential dangers of pink cocaine.

Its aesthetic look and “designer drug” status have contributed to its appeal, particularly among young people and first-time users. This mirrors the historical allure of drugs like cocaine and MDMA. It highlights a persistent trend where certain substances are glamourised despite their risks.

Experts compare taking pink cocaine to playing Russian Roulette with substance use, underscoring the unpredictable and dangerous nature of pink cocaine.

The drug has spread beyond Ibiza to the UK, and there is evidence that it has gained traction in Scotland, parts of Wales and England. Across the Atlantic, New York City has also seen a surge in its availability.